EKGGF (CardioComm Solutions) 5-Day RSI: 100.00 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CardioComm Solutions 5-Day RSI?

CardioComm Solutions EKGGF 5-Day RSI is 100.00 as of Aug. 02, 2026. The stock has 8 warning signs investors should review. Among 693 Healthcare Providers & Services companies, CardioComm Solutions ranks better than 97.4% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-08-02), CardioComm Solutions's 5-Day RSI is 100.00.

The industry rank for CardioComm Solutions's 5-Day RSI or its related term are showing as below:

EKGGF's 5-Day RSI is ranked better than
97.4% of 693 companies
in the Healthcare Providers & Services industry
Industry Median: 48.24 vs EKGGF: 100.00

CardioComm Solutions  (OTCPK:EKGGF) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


CardioComm Solutions 5-Day RSI Related Terms


EKGGF vs VEEV, BTSG, HQY: 5-Day RSI Comparison

For the Health Information Services subindustry, CardioComm Solutions's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioComm Solutions 5-Day RSI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where CardioComm Solutions's 5-Day RSI falls into.



CardioComm Solutions  (OTCPK:EKGGF) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 5-Day RSI →
What does a 5-Day RSI of 100.00 mean?
CardioComm Solutions (EKGGF) has a 5-Day RSI of 100.00 as of Aug. 02, 2026. According to the industry distribution chart, CardioComm Solutions ranks #18 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 2.6%.
Is CardioComm Solutions' 5-Day RSI too high?
CardioComm Solutions' current 5-Day RSI is 100.00. The Healthcare Providers & Services industry median 5-Day RSI is 48.24. CardioComm Solutions' value of 100.00 is 107.3% above this industry median. Based on the distribution chart, CardioComm Solutions ranks #18 out of 693 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does CardioComm Solutions' 5-Day RSI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CardioComm Solutions ranks #18 out of 693 companies for 5-Day RSI. This places CardioComm Solutions in the top 3% of its industry — outperforming the majority of peers. The industry median 5-Day RSI is 48.24. CardioComm Solutions' value of 100.00 is 107.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Healthcare Providers & Services company?
The median 5-Day RSI among Healthcare Providers & Services companies is 48.24, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CardioComm Solutions's current 5-Day RSI of 100.00 is 107.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 5-Day RSI is 48.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CardioComm Solutions's current 5-Day RSI is 100.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (EKGGF) has a current 5-Day RSI of 100.00. The current 5-Day RSI is 100.00 and 107.3% above the Healthcare Providers & Services industry median of 48.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For CardioComm Solutions (EKGGF), the current 5-Day RSI is 100.00 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CardioComm Solutions Business Description

Other Exchanges EKG:Canada
Address 110 Sheppard Avenue East, Suite 700, North York, ON, CAN, M2N 6Y8
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.